Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence summary of best practices for prevention and management of postpartum hemorrhage in obstetric clinical practice.

Frontiers in medicine·2026
Same author

MR Lymphangiography for Diagnosis of Lower Extremity Lymphedema: Suppressing Venous Signal Interference Using Deep Learning.

Radiology·2026
Same author

PhenolFingerprint DB: an open-access platform for phenolic fingerprinting, quantification, and automated species authentication, validated on 93 floral and herbal plants.

Food chemistry·2026
Same author

Variable efficacy of the non-covalent KRAS<sup>G12D</sup> inhibitor (MRTX-1133) with obesity in murine pancreatic cancer.

NPJ precision oncology·2026
Same author

[Association between mixed exposure to 11 urinary metal elements and the risk of thyroid cancer: a case-control study].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences·2026
Same author

Short-, medium-, and long-chain chlorinated paraffins in human serum from South China: Evidence of LCCP exposure and CP substitution.

Journal of hazardous materials·2026

Related Experiment Video

Updated: Mar 15, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K

Serum protein profiling in diffuse large B-cell lymphoma.

Jacques Riby1,2, James Mobley2,3, Jianqing Zhang1,2

  • 1Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

Proteomics. Clinical Applications
|August 26, 2016
PubMed
Summary

This pilot study identified five key proteins elevated in diffuse large B-cell lymphoma (DLBCL) patients, suggesting potential biomarkers for this cancer. Further research is needed to confirm their role in DLBCL. Keywords: diffuse large B-cell lymphoma, DLBCL, biomarkers, proteomics.

Keywords:
BiomarkerDLBCLLCMSNHLSerum proteomics

More Related Videos

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.8K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

12.6K

Related Experiment Videos

Last Updated: Mar 15, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.8K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

12.6K

Area of Science:

  • Proteomics
  • Biomarker Discovery
  • Oncology

Background:

  • Diffuse large B-cell lymphoma (DLBCL) is a significant hematologic malignancy.
  • Identifying reliable biomarkers for DLBCL is crucial for diagnosis and prognosis.
  • Current diagnostic and prognostic tools require improvement.

Purpose of the Study:

  • To perform exploratory proteomics profiling on sera from DLBCL patients.
  • To identify potential disease-specific protein biomarkers for DLBCL.
  • To lay the groundwork for future biomarker validation studies.

Main Methods:

  • Nontargeted liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used for serum proteomics.
  • Sera from 57 chemotherapy-naïve DLBCL patients and 30 controls were analyzed.
  • Differential protein abundance was assessed using statistical analysis (p-adjusted <0.05).

Main Results:

  • Thirty-five proteins showed differential abundance between DLBCL patients and controls.
  • Five proteins (adiponectin, CD14, HSPG2, ECM1, ACT) were significantly elevated in DLBCL sera.
  • ELISA confirmed statistically significant elevations for these five candidate biomarkers.

Conclusions:

  • Preliminary proteomics data suggest potential serum biomarkers for DLBCL.
  • Adiponectin, CD14, HSPG2, ECM1, and ACT warrant further investigation.
  • Clinical and prospective studies are needed to validate these biomarkers for DLBCL pathogenesis and prognosis.